Key Takeaways
- • Bain Capital Private Equity invests in CitiusTech alongside existing majority shareholder BPEA EQT (which acquired its stake in 2019), creating a dual-anchor ownership structure in the healthcare technology and consulting provider.
- • CitiusTech has more than doubled revenues since BPEA EQT's 2019 investment, demonstrating strong operational scaling in digital healthcare technology and AI-driven solutions.
- • The company serves over 130 leading healthcare and life sciences organizations, with platform investments focused on value-based performance, technology modernization, patient engagement, medical imaging, and digital health transformation.
- • Financial terms were not disclosed, consistent with private equity transaction confidentiality standards; deal structure involves Bain Capital joining as investor rather than acquiring control.
- • Both investors emphasize healthcare technology sector tailwinds, with CEO Bhaskar Sambasivan citing continued industry embrace of digital and AI-driven solutions as a growth driver.
Summary
CitiusTech, a leading provider of technology and consulting services to healthcare and life sciences organizations, announced a strategic investment from Bain Capital Private Equity on October 20, 2022. Bain Capital joins existing shareholder BPEA EQT (Baring Private Equity Asia), which acquired a majority stake in CitiusTech in 2019. Financial terms of the private transaction were not disclosed.
The investment reflects confidence in CitiusTech's growth trajectory and market positioning. Since BPEA EQT's 2019 acquisition, the company has more than doubled its revenues, demonstrating strong operational execution in a sector experiencing accelerated digital transformation. CEO Bhaskar Sambasivan characterized the partnership as aligning CitiusTech with "two of the world's leading investment firms," both with established track records scaling healthcare and technology businesses. The dual-investor structure signals neither party is taking a controlling stake but rather co-investing to support further expansion.
CitiusTech was founded in 2005 and currently serves over 130 healthcare and life sciences organizations. The company offers a range of digital healthcare technology and consulting services designed to help clients deliver better patient outcomes, transform care and business processes, and improve operational efficiency. Core platform investments address industry-critical needs including value-based care performance management, technology modernization, patient engagement solutions, medical imaging applications, digital front-door capabilities, and broader digital health transformation initiatives.
The investment aligns with structural trends in healthcare services. As the sector increasingly adopts digital and AI-driven solutions, CitiusTech has positioned itself with proprietary platforms and scalable, repeatable solutions. Sambasivan stated the Bain Capital investment would enable the company to "continue to scale and innovate, to better serve existing and new customers, and enable healthcare organizations to become more care-efficient, personalized, and data-driven."
The investment reflects confidence in CitiusTech's growth trajectory and market positioning. Since BPEA EQT's 2019 acquisition, the company has more than doubled its revenues, demonstrating strong operational execution in a sector experiencing accelerated digital transformation. CEO Bhaskar Sambasivan characterized the partnership as aligning CitiusTech with "two of the world's leading investment firms," both with established track records scaling healthcare and technology businesses. The dual-investor structure signals neither party is taking a controlling stake but rather co-investing to support further expansion.
CitiusTech was founded in 2005 and currently serves over 130 healthcare and life sciences organizations. The company offers a range of digital healthcare technology and consulting services designed to help clients deliver better patient outcomes, transform care and business processes, and improve operational efficiency. Core platform investments address industry-critical needs including value-based care performance management, technology modernization, patient engagement solutions, medical imaging applications, digital front-door capabilities, and broader digital health transformation initiatives.
The investment aligns with structural trends in healthcare services. As the sector increasingly adopts digital and AI-driven solutions, CitiusTech has positioned itself with proprietary platforms and scalable, repeatable solutions. Sambasivan stated the Bain Capital investment would enable the company to "continue to scale and innovate, to better serve existing and new customers, and enable healthcare organizations to become more care-efficient, personalized, and data-driven."
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.